# Effect of Alpha Lipoic Acid on Non-alcoholic Fatty Liver Diseases

> **NCT04475276** · PHASE4 · COMPLETED · sponsor: **All India Institute of Medical Sciences, Bhubaneswar** · enrollment: 120 (actual)

## Conditions studied

- Non-Alcoholic Fatty Liver Disease

## Interventions

- **DRUG:** Placebo
- **DRUG:** Alphalipoic acid

## Key facts

- **NCT ID:** NCT04475276
- **Lead sponsor:** All India Institute of Medical Sciences, Bhubaneswar
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-23
- **Primary completion:** 2023-12-31
- **Final completion:** 2024-01-01
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2025-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04475276

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04475276, "Effect of Alpha Lipoic Acid on Non-alcoholic Fatty Liver Diseases". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04475276. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*